Razvojni put

Tretmani izvan bezglutenske dijete

Nekoliko pristupa je došlo do randomiziranih ispitivanja. Nijedan nije zamijenio dijetu, a polje ima dugu historiju obećavajućih rezultata koji nisu održani.

Ažurirano 2 min čitanja 39 citati Snaga dokaza 3/5

Ispis sastojaka na poleđini pakovanja hrane
Chenspec · CC BY-SA 4.0 · Wikimedia Commons

Zašto je lijek teško razviti

Celijakija ima neobičnu osobinu među autoimunim stanjima: okidač je poznat i uklonjiv. To postavlja vrlo visoke standarde — svaki lijek mora biti sigurniji i praktičniji od jednostavnog nejedanja glutena, u populaciji koja nije akutno bolesna nakon liječenja. Također, to znači da realističan cilj nije "ponovo jesti hljeb" već "biti zaštićen kada restoran pogriješi".

Inhibicija transglutaminaze 2

Tjelesna transglutaminaza modificira peptide glutena na način koji ih čini daleko imunogenijim — to je enzim u središtu mehanizma bolesti i cilj antitijela koje se koristi za dijagnosticiranje. Njegovo blokiranje je stoga mehanistički elegantno. Randomizirano ispitivanje TG2 inhibitora izvijestilo je o ublažavanju oštećenja sluznice izazvanog glutenom tokom izazova [5], što je najhrabriji pojedinačni rezultat koji je polje proizvelo.

Inhibicija TG2

Enzimska razgradnja

Glutenaze imaju za cilj razgradnju glutena u želucu prije nego što dođe do tankog crijeva. Inženjerski problem je ozbiljnost: da bi se zaštitili od normalnog obroka pšenice, enzim mora razgraditi grame proteina u neprijateljskom kiselom okruženju unutar kratkog vremenskog okvira. Nekoliko kandidata je pokazalo aktivnost protiv malih količina bez demonstriranja zaštite od realističnog izlaganja. Rad na probiotskim pripravcima s in vivo aktivnošću razgradnje glutena ilustrira pristup.

Probiotici

Sistematski pregled i meta-analiza randomiziranih kontroliranih ispitivanja probiotika za celijakiju postoje i ne podržavaju rutinsku upotrebu. Razlike u mikrobiomu kod celijakije su stvarne i reproducibilne, ali njihovo modificiranje nije dovelo do klinične koristi.

Ostale smjernice

  • Indukcija imunološke tolerancije. Pristupi zasnovani na peptidima koji imaju za cilj ponovno obučiti imunološki odgovor, konceptualno slični imunoterapiji alergena.
  • Modulacija čvrstih spojeva. Smanjenje intestinalne propusnosti kako bi se manje peptida glutena prešlo. Ispitivanja su bila mješovita.
  • Blokada citokina. Usmjerena na refraktornu bolest, a ne na običnu celijakiju [7].
  • Vakcinacija. Dugo raspravljana, više puta odložena i nije blizu.

Šta očekivati

Mogući sljedeći korak je dodatak koji smanjuje posljedice slučajnog izlaganja za ljude koji su već strogi. To bi bilo zaista vrijedno — nenamjerno izlaganje je uobičajeno, kao što pokazuje istraživanje o kontaminaciji — bez da predstavlja slobodu koju pokrivenost obično obećava.

Tekst sastojaka otisnut na ambalaži hrane
Chenspec · CC BY-SA 4.0 · Wikimedia Commons

Česta pitanja

Hoće li biti tableta koja mi omogućava da jedem hljeb?
Ne prema trenutnim dokazima. Ispitivanja se fokusiraju na zaštitu od kontaminacije, a ne na nastavak normalne dijete.
Trebam li uzimati enzim za probavljanje glutena?
Nisu pokazali zaštitu od izlaganja glutenu u veličini obroka, a oslanjanje na jedan je rizično.
Da li vrijedi probati probiotike?
Meta-analiza randomiziranih ispitivanja ne podržava ih specifično za celijakiju.
Kako bih se pridružio ispitivanju?
Nacionalna društva za celijakiju i registri kliničkih ispitivanja navode studije koje regrutuju; vaš gastroenterolog može savjetovati o podobnosti.
Dokazi iza ove stranice Stogasti grafikon koji prikazuje sastav 16 publikacija citiranih na ovoj stranici prema tipu studije. 61101meta-analysis (6)randomised trial (1)review (10)other (1)
16 publikacija, 2006–2025. Ovo je uglavnom opservacijska osnova. Može utvrditi da se stvari dešavaju zajedno; ne može odrediti koja uzrokuje drugu. Izvor: vlastita lista citata ove stranice, ispod.

Reference

Svaka citacija u nastavku povezuje na izvorni recenzirani zapis na PubMed-u ili putem DOI-a. Ništa ovdje nije zamjena za medicinski savjet.

  1. European Society for the Study of Coeliac Disease (ESsCD) 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 2: Management, Follow-Up, and Complex Disease Courses Al-Toma A, Branchi F, Zingone F, et al. · United European gastroenterology journal · 2026 · Clinical guideline DOIPubMed 41831197Full text
  2. Prebiotic Supplementation in Celiac Disease: A Systematic Review of Clinical Efficacy, Safety, and Nutritional Outcomes Shahzil M, Irfan MZ, Kazmi SK, et al. · Journal of gastrointestinal and liver diseases : JGLD · 2026 · Systematic review DOIPubMed 42365652
  3. Physical Activity in Patients with Celiac Disease: A Systematic Review Zapata-Martínez I, Herrador-López M, Navas-López VM, et al. · Nutrients · 2026 · Systematic review DOIPubMed 42514469Full text
  4. Assessment of growth status and nutritional management of prematurely born infants after hospital discharge: A position paper of the ESPGHAN Nutrition Committee Haiden N, Luque V, Domellöf M, et al. · Journal of pediatric gastroenterology and nutrition · 2025 · Clinical guideline DOIPubMed 40341618
  5. European Society for the Study of Coeliac Disease 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 1: Diagnostic Approach Al-Toma A, Zingone F, Branchi F, et al. · United European gastroenterology journal · 2025 · Clinical guideline DOIPubMed 40999951Full text
  6. Italian guidelines for the diagnosis and treatment of functional dyspepsia - joint consensus from the Italian societies of gastroenterology and endoscopy (SIGE), Neurogastroenterology and motility (SINGEM), hospital gastroenterologists and endoscopists (AIGO), digestive endoscopy (SIED) and general medicine (SIMG) Sarnelli G, Pesce M, Barbara G, et al. · Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2025 · Clinical guideline DOIPubMed 40628573
  7. Updated joint ESPGHAN/NASPGHAN guidelines for management of Helicobacter pylori infection in children and adolescents (2023) Homan M, Jones NL, Bontems P, et al. · Journal of pediatric gastroenterology and nutrition · 2024 · Clinical guideline DOIPubMed 39148213
  8. Diet-microbiota associations in gastrointestinal research: a systematic review Duncanson K, Williams G, Hoedt EC, et al. · Gut microbes · 2024 · Systematic review DOIPubMed 38725230Full text
  9. Psychological, Psychiatric, and Organic Brain Manifestations of Celiac Disease Ciaccio EJ, Lee AR, Lebovits J, et al. · Digestive diseases (Basel, Switzerland) · 2024 · Systematic review DOIPubMed 38861947
  10. Single-Cell Meta-Analysis of Neutrophil Activation in Kawasaki Disease and Multisystem Inflammatory Syndrome in Children Reveals Potential Shared Immunological Drivers Beltran JVB, Lin FP, Chang CL, et al. · Circulation · 2023 · Meta-analysis DOIPubMed 37905415
  11. Celiac disease and COVID-19 in adults: A systematic review Amirian P, Zarpoosh M, Moradi S, et al. · PloS one · 2023 · Systematic review DOIPubMed 37192180Full text
  12. ACG Clinical Guideline: Management of Irritable Bowel Syndrome Lacy BE, Pimentel M, Brenner DM, et al. · The American journal of gastroenterology · 2021 · Clinical guideline DOIPubMed 33315591
  13. The role of gluten-free diet in nonalcoholic fatty liver disease development Larussa T, Abenavoli L, Procopio AC, et al. · European review for medical and pharmacological sciences · 2021 · Systematic review DOIPubMed 34787864
  14. Gluten sensitivity and epilepsy: a systematic review Julian T, Hadjivassiliou M, Zis P · Journal of neurology · 2019 · Systematic review DOIPubMed 30167878Full text
  15. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders Al-Toma A, Volta U, Auricchio R, et al. · United European gastroenterology journal · 2019 · Clinical guideline DOIPubMed 31210940Full text
  16. ACG clinical guidelines: diagnosis and management of celiac disease Rubio-Tapia A, Hill ID, Kelly CP, et al. · The American journal of gastroenterology · 2013 · Clinical guideline DOIPubMed 23609613Full text
  17. American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases Gastroenterology · 2003 · Clinical guideline DOIPubMed 12612916
  18. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology Scott EM, Gaywood I, Scott BB · Gut · 2000 · Clinical guideline DOIPubMed 10647595Full text
  19. Hepatic Steatosis and Diet in Adult Celiac Disease: A Cross-Sectional Study Peresztegi MZ, Szakács Z, Farkas N, et al. · Nutrients · 2025 · Randomised controlled trial DOIPubMed 41305627Full text
  20. Effect of Aspergillus niger prolyl endopeptidase in patients with celiac disease on a long-term gluten-free diet Stefanolo JP, Segura V, Grizzuti M, et al. · World journal of gastroenterology · 2024 · Randomised controlled trial DOIPubMed 38617446Full text
  21. A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease Schuppan D, Mäki M, Lundin KEA, et al. · The New England journal of medicine · 2021 · Randomised controlled trial DOIPubMed 34192430
  22. Chapter 4: Differential diagnosis of primary hyperparathyroidism Kamenický P, Houillier P, Vantyghem MC · Annales d'endocrinologie · 2025 · Review DOIPubMed 39818292
  23. Rotavirus Infections: Pathophysiology, Symptoms, and Vaccination Pawłuszkiewicz K, Ryglowski PJ, Idzik N, et al. · Pathogens (Basel, Switzerland) · 2025 · Review DOIPubMed 40430800Full text
  24. AGA Clinical Practice Update on Management of Iron Deficiency Anemia: Expert Review DeLoughery TG, Jackson CS, Ko CW, et al. · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2024 · Review DOIPubMed 38864796
  25. Advances in Nonresponsive and Refractory Celiac Disease Malamut G, Soderquist CR, Bhagat G, et al. · Gastroenterology · 2024 · Review DOIPubMed 38556189
  26. AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and Distention: Expert Review Moshiree B, Drossman D, Shaukat A · Gastroenterology · 2023 · Review DOIPubMed 37452811
  27. AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review Green PHR, Paski S, Ko CW, et al. · Gastroenterology · 2022 · Review DOIPubMed 36137844
  28. Celiac disease and bone Kondapalli AV, Walker MD · Archives of endocrinology and metabolism · 2022 · Review DOIPubMed 36382765Full text
  29. Epidemiology of Non-Hodgkin's Lymphoma Thandra KC, Barsouk A, Saginala K, et al. · Medical sciences (Basel, Switzerland) · 2021 · Review DOIPubMed 33573146Full text
  30. Small and Large Intestine (I): Malabsorption of Nutrients Montoro-Huguet MA, Belloc B, Domínguez-Cajal M · Nutrients · 2021 · Review DOIPubMed 33920345Full text
  31. Medical Care of Adults With Down Syndrome: A Clinical Guideline Tsou AY, Bulova P, Capone G, et al. · JAMA · 2020 · Review DOIPubMed 33079159
  32. Gluten-related disorders: Celiac disease, wheat allergy, and nonceliac gluten sensitivity Cabanillas B · Critical reviews in food science and nutrition · 2020 · Review DOIPubMed 31402697
  33. Osteoporosis and inflammation Lacativa PG, Farias ML · Arquivos brasileiros de endocrinologia e metabologia · 2010 · Review DOIPubMed 20485900
  34. Celiac disease Rodrigo L · World journal of gastroenterology · 2006 · Review DOIPubMed 17075969Full text
  35. [Adult celiac disease] Cellier C, Grosdidier E · La Revue du praticien · 2001 · Review PubMed 11458609
  36. Small intestinal lymphoma Cooper BT, Read AE · World journal of surgery · 1985 · Review DOIPubMed 3936285
  37. Reply Walker MD, Lebwohl B, Green PHR · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2020 · Journal article DOIPubMed 31376492
  38. Tempters and Gluten-Free Diet Catassi C, Fasano A · Nutrients · 2016 · Journal article DOIPubMed 27918479Full text
  39. Not knowing Mantovani JF · Developmental medicine and child neurology · 2003 · Journal article PubMed 12578231

Ova stranica je automatski prevedena sa engleskog. Citati i brojevi su nepromijenjeni. Pročitajte engleski original ako nešto zvuči čudno. Pročitajte engleski original